FDA Provides Positive Feedback to Vistagen Regarding Use of the Liebowitz Social Anxiety Scale as an Endpoint in Phase 3 Development of Fasedienol for Treatment of Social Anxiety Disorder - Marketscreener.com
Submitted by Anonymous (not verified) on Fri, 03/31/2023 - 11:54
